Q3 2014

Filed Nov 13, 2014 · 10-Q · 44 days after period end · 0001583648-14-000012

Q3 2014 · 10-Q

Revenue

$18.72K

no prior Q3 2013 on file

Net Income

-$2.02M

no prior Q3 2013 on file

EPS Diluted

-$0.17

no prior Q3 2013 on file

Operating Income-$1,841,093—

Operating Cash Flow

Same quarter

no prior Q3 2013 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Sep 30, 2014 · filed Nov 13, 2014 · 44 d after period end

Palvella Therapeutics, Inc. · CIK 1583648 · Engraved from SEC EDGAR